Top Story

Potential biomarker identified for neonatal sepsis in preterm infants

March 3, 2015

MEMPHIS, Tenn. — Leena Mithal, MD, pediatric infectious diseases fellow at Ann and Robert H. Lurie Children’s Hospital of Chicago, discusses new research which found that acute phase reactants in cord blood of premature infants could be used in detection and risk stratification for early onset sepsis.

While early onset sepsis in neonates continues to be a significant cause of morbidity and mortality, there are insufficient clinical and laboratory diagnostics available to apply necessary antibiotic prophylaxis.

Jared Baeten Meeting News Coverage

PrEP as bridge to ART highly successful in HIV prevention

March 3, 2015
SEATTLE — A project integrating time-limited pre-exposure prophylaxis along with ART among high-risk, serodiscordant couples demonstrated an observed HIV incidence of…
In the Journals

Earlier antibiotics lead to better outcomes with Rocky Mountain spotted fever

March 3, 2015
Recent data suggest earlier treatment with doxycycline may reduce morbidity and mortality in American Indian patients with Rocky Mountain spotted fever. Although Rocky…
Meeting News Coverage

HIV testing in ED serves as link to care

March 3, 2015
SEATTLE — An HIV testing program in an ED, which was originally implemented to describe the local epidemic, played a significant role in linking individuals to…
In the Journals

Abnormalities related to C. gattii may be slow to resolve

March 3, 2015
Resolution of cryptococcomas and serum antigenemia related to Cryptococcus gattii infection was slow among patients, but late onset of treatment failure or relapse…
More News Headlines »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
Meeting News Coverage Video
thumbnail for video 4083320513001

Video: Highlights in cancer and HIV treatments at CROI 2015

February 27, 2015
Infectious Disease News Editorial Board member Paul Volberding, MD, reviews HIV and cancer treatment data presented…
More »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
morganatic-roan